New combo shrinks rectal tumors before surgery
NCT ID NCT04417699
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tested a shorter radiation course combined with TASOX chemotherapy in 13 people with stage II/III rectal cancer. The goal was to shrink tumors before surgery. Results showed the treatment was safe and helped reduce tumor stage, allowing for complete removal. This approach may offer a condensed treatment option for intermediate-risk rectal cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center/NYPH
New York, New York, 10032, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
University of California, Irvine
Orange, California, 92868, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.